Pharmacological Preconditioning of Mesenchymal Stem Cells with Trimetazidine (1-[2,3,4-Trimethoxybenzyl]piperazine) Protects Hypoxic Cells against Oxidative Stress and Enhances Recovery of Myocardial Function in Infarcted Heart through Bcl-2 Expression-Reference-Cited by-同舟云学术

Pharmacological Preconditioning of Mesenchymal Stem Cells with Trimetazidine (1-[2,3,4-Trimethoxybenzyl]piperazine) Protects Hypoxic Cells against Oxidative Stress and Enhances Recovery of Myocardial Function in Infarcted Heart through Bcl-2 Expression

Published:2009-02-13 Issue:2 Volume:329 Page:543-550
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Wisel Sheik,Khan Mahmood,Kuppusamy M. Lakshmi,Mohan I. Krishna,Chacko Simi M.,Rivera Brian K.,Sun Benjamin C.,Hideg Kálmán,Kuppusamy Periannan

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference40 articles.

1. Trimetazidine inhibits mitochondrial permeability transition pore opening and prevents lethal ischemia–reperfusion injury

2. Role of Oxidative Metabolism on Endothelium-dependent Vascular Relaxation of Isolated Vessels

3. Cell-Based Therapy of Myocardial Infarction

4. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals

5. Adverse effects of free fatty acid associated with increased oxidative stress in postischemic isolated rat hearts

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trimetazidine improves angiogenesis and tissue perfusion in ischemic rat skeletal muscle;Frontiers in Pharmacology;2024-07-23

2. Emerging Strategies in Mesenchymal Stem Cell-Based Cardiovascular Therapeutics;Cells;2024-05-17

3. Evaluation of the pharmacokinetics, bioequivalence, and safety of two preparations of 20 mg trimetazidine;2024-02-28

4. Injectable hydrogel-based combination therapy for myocardial infarction: a systematic review and Meta-analysis of preclinical trials;BMC Cardiovascular Disorders;2024-02-21

5. Injectable Hydrogel-Based Combination Therapy for Myocardial Infarction: A Systematic Review and Meta-Analysis of Preclinical Trials;2023-10-11